# ZILXI
> **NDA213690** · New Drug Application · Sponsor: JOURNEY · Approved 2020-05-28
## Drug
- **FDA Application Number:** NDA213690
- **Application type:** New Drug Application
- **Brand name:** ZILXI
- **Generic name:** MINOCYCLINE
- **Active ingredients:** MINOCYCLINE HYDROCHLORIDE
- **Dosage form:** AEROSOL, FOAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** JOURNEY
- **Manufacturer:** Journey Medical Corporation
- **First approval:** 2020-05-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213690)
---
*AI Analytics · CC0 1.0*